PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go:
Extended
investment:
£295,000
Plerith works with high growth start-ups and scaling companies to plan for and deliver growth. The company asserts that it helps companies promote their business to potential funders, through its network of angel and venture capital investors depending on the stage and sector of the said business. Plerith is partnering with Newable and Bristol Private Equity Club to deliver the fund in the South West London (SWL) area and identify and invest in the most exciting high growth companies in the region. Plerith argues that its deep knowledge of fundraising, sales, strategy, finance and technology would help SWL businesses flourish. Plerith aims to provide investors access to the highest quality local companies in the SWL region.
days to go:
Stretch
investment:
Withheld
Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go:
Extended
investment:
Withheld
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go:
TBC
investment:
£127,001
Baanx is a B2B2C mobile banking platform offering cutting-edge services in remittance, spending & blockchain. The company takes pride in its innovative customer acquisition process through partner communities. The BaanxCL already has a CL™ VISA Debit Card, Crypto-Payment Gateway, a Crypto-Exchange, Stablecoins, and other exciting features. The company is also partnering with new brands around the world which are not banking already but have large user communities to connect. The company is aiming to target 100,000 users by Q2 2020 with the assistance of Super Seed Investors. With the proceeds, Baanx will hire additional team members, spend funds on marketing, and launch services in South America and Asia.
days to go:
Expired
investment:
£658,200
Uspaah offers wellness and beauty treatments to clients at their homes, offices and hotels in as little as an hour, all booked via a simple mobile application. This company has reached £264k gross sales y/e Mar 2018, resulting in 58k revenue (-£17k P+L). It utilised the previous Crowdcube investment and its own capital to generate the total accumulated revenue growth of 841% and completed jobs growth of 933%. Presently, it has over 15000 registered users in London and its team has grown from a mere 70 to almost 200 people. With the proceeds, it's planning to scale-up the previous model. Additionally, it aims to double or even triple its client base in the next 18 to 24 months.
days to go:
Expired
investment:
£175,460
A web-based location experience platform for businesses to market their content for their target audience by users visiting physical locations to view digital content. Landmrk's service is currently used by travel, entertainment and retail industries and allows businesses to provide 'rewards' when customers reach the location. Revenue is primarily generated from marketing agencies and businesses licensing the platform on a monthly, quartely or annual basis.
days to go:
Expired
investment:
£519,364
Multiple brokers and clients can connect with each other on the only FCA-regulated social trading app. Pelican's platform is designed for traders to discuss strategies and share, copy, oppose or execute trades similarly to traditional traders on Bloomberg terminals. Revenue is generated via client-trading rebates and subscriptions from users following good traders and mentors. Further B2B revenue streams include set-up and monthly service fees.
days to go:
Expired
investment:
£465,209
Equipsme is on a mission to democratise health insurance by making it affordable for businesses of all sizes. The company cites data arguing that there has been a 53% increase in National Health Service (NHS) treatment waiting lists since 2012 due to the low reach of health insurance by conventional insurance companies. It aims to change this scenario. Equipsme offers flexible fixed-price packages to companies wherein employees are allowed to upgrade and add family members to their plan as per their pleasure. Members can also speak to a General Physician (GP) 24/7, and, if necessary, be referred to a consultant for diagnosis and treatment through the company's proprietary app. The company was felicitated with the 'Best New Product' award by Cover Magazine Excellence Awards 2019. The company will use the investment to enhance its user experience, ensure its technology remains market-leading, and scale its marketing and customer service capability.
days to go:
Expired
investment:
£286,096
ReCircle Recycling has designed an appliance meant for installation in households, businesses and new developments to grind glass bottles, compact metal cans, and flake plastic packaging straight into ready to use manufacturing material. This process allows Recircle Recycling to set up a new closed-loop system where packaging is endlessly recycled. It increases the purity and value of all the materials. When manufacturers finally have access to high-grade recycled to minimise their carbon footprints and where consumers and businesses receive payback for the true value of their recycled product. ReCircle collects and delivers materials from a common man's curb 3-8 times a year. It has established strong connections and technology developments with the UK University. ReCircle has also filed patents with the USA, Japan, China, Europe, and India. ReCircle is also building a close relationship with Swansea University. It intends to launch in California, which has the highest recycling rate in the US.
days to go:
Expired
investment:
£548,150
